Recognized R&D Pioneers in Anti-Inflammatory Therapeutics

The founding team members at 180 Life Sciences Corp. (NASDAQ: ATNF) are the recognized pioneers of research and development in anti-inflammatory therapeutics.

180 Life Sciences is a clinical-stage biotechnology company that brings together the expertise of world-renowned scientists to develop and test novel treatments for inflammation and is currently working in both preclinical and clinical studies.

finance.yahoo.com/news/180-life-sciences-corp-nasdaq-123000501.html